Side-by-side comparison of AI visibility scores, market position, and capabilities
Maven Clinic is the largest virtual clinic for women and families, providing care across fertility, maternity, menopause, and pediatrics through employer and health plan benefits.
Maven Clinic is a digital health company founded in 2014 by Kate Ryder that has grown into the largest virtual care platform dedicated to women and family health, raising over $300M at a $1.35B valuation. The company provides a comprehensive virtual clinic covering fertility, maternity, menopause, family planning, pediatric care, and general women's health through a network of OB-GYNs, midwives, reproductive endocrinologists, nutritionists, mental health specialists, and other providers. Maven distributes primarily through employer health benefits programs and health plan partnerships, serving over 30 million covered lives through partnerships with large employers and insurers. The platform has demonstrated significant return on investment for employers through reduced NICU costs, lower preterm birth rates, and improved fertility treatment outcomes. Maven has expanded internationally to serve global employers managing diverse populations across multiple countries. The company competes with Progyny in fertility benefits and with Hims & Hers and other women's health platforms in the direct-to-consumer market while maintaining the broadest clinical scope of any women's and family health platform.
Noom is a digital weight health program combining psychology-based behavioral coaching, food logging, and human coaching to help members build sustainable healthy habits.
Noom is a digital health company founded in 2008 that has grown into one of the most widely used weight management platforms, serving millions of members through its psychology-driven approach to behavior change. The platform combines daily lessons on cognitive behavioral techniques, food logging with a traffic-light color-coding system, personal coaching from trained health coaches, and group support to help members change their relationship with food and exercise. Noom raised over $540M and reached a $3.7B valuation, establishing it as a leading consumer digital health company. The company has expanded beyond weight loss into a broader weight health platform addressing both weight management and weight-related conditions including type 2 diabetes management with its Noom Med offering that includes GLP-1 medication prescribing. As GLP-1 medications like Ozempic and Wegovy have transformed the weight loss market, Noom has positioned its behavioral coaching as essential to sustainable results alongside medication. The platform serves both direct-to-consumer subscribers and employer health plans that offer Noom as a weight management benefit for their workforces.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.